Office of the Director, National Institutes of Health Notice of Meeting, 64487 [2020-22600]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 198 / Tuesday, October 13, 2020 / Notices
Date: November 9–10, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jonathan Arias, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5170,
MSC 7840 Bethesda, MD 20892, 301–435–
2406, ariasj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Health Services Organization and
Delivery.
Date: November 9, 2020.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lauren Fordyce, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3214,
Bethesda, MD 20892, (301) 827–8269,
fordycelm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 6, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–22523 Filed 10–9–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
VerDate Sep<11>2014
18:52 Oct 09, 2020
Jkt 253001
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: November 4, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G42B,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Louis A. Rosenthal, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institutes of Health, National
Institute of Allergy and Infectious Diseases,
5601 Fishers Lane, Room 3G42B, Bethesda,
MD 20892–9834, (240) 669–5070,
rosenthalla@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 6, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–22524 Filed 10–9–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Novel and Exceptional
Technology and Research Advisory
Committee.
The meeting will be held as a virtual
meeting and is open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting, should notify the
Contact Person listed below in advance
of the meeting. The meeting will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
Name of Committee: Novel and
Exceptional Technology and Research
Advisory Committee.
Date: November 9, 2020.
Time: 10:00 a.m. to 5:15 p.m.
Agenda: The Novel and Exceptional
Technology and Research Advisory
Committee (NExTRAC) will include a
workshop to examine existing biosafety
guidance for contained gene drive research
and to discuss potential conditions under
which NIH could consider supporting field
release of gene drive-modified organisms.
Place: National Institutes of Health, 6705
Rockledge Drive, Suite 750, Bethesda, MD
20892, (Virtual Meeting—Link for the
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
64487
meeting will be available at https://
osp.od.nih.gov/biotechnology/main-nextrac/
#meetings).
Name of Committee: Novel and
Exceptional Technology and Research
Advisory Committee.
Date: November 10, 2020.
Time: 10:00 a.m. to 5:15 p.m.
Agenda: The Novel and Exceptional
Technology and Research Advisory
Committee (NExTRAC) will include (1) a
workshop to examine existing biosafety
guidance for contained gene drive research
and to discuss potential conditions under
which NIH could consider supporting field
release of gene drive-modified organisms,
and (2) discussion of a draft report
conceptualizing a framework for NExTRAC
deliberation of issues surrounding emerging
biotechnologies.
Place: National Institutes of Health, 6705
Rockledge Drive, Suite 750, Bethesda, MD
20892, (Virtual Meeting—Link for the
meeting will be available at https://
osp.od.nih.gov/biotechnology/main-nextrac/
#meetings).
Contact Person: Kinshasa Letts, Office of
Science Policy, National Institutes of Health,
6705 Rockledge Drive, Suite 750, Bethesda,
MD 20892, 301–496–9838, SciencePolicy@
od.nih.gov.
To sign up to make an oral public
comment, please submit your name,
affiliation, and short description of the oral
comment to the Contact Person listed above
by 5:00 p.m. EST, November 3, 2020. Sign up
will be restricted to one sign up per email
and oral comments will be limited to two
minutes. Once all time slots are filled, only
written comments will be accepted. Any
interested person may file written comments
by forwarding their statement to the Contact
Person listed on this notice. The Contact
Person should receive any written statements
by 5:00 p.m. EST, November 5, 2020.
Information is also available on the
NExTRAC web page: https://osp.od.nih.gov/
biotechnology/main-nextrac/#meetings,
where an agenda and any additional
information for the meeting will be posted
when available. The Draft Report of the
Working Group to Establish a NExTRAC
Framework will be posted prior to the
meeting. Please check this website for
updates.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: October 7, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–22600 Filed 10–9–20; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\13OCN1.SGM
13OCN1
]]>Agencies
[Federal Register Volume 85, Number 198 (Tuesday, October 13, 2020)]
[Notices]
[Page 64487]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22600]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Novel and
Exceptional Technology and Research Advisory Committee.
The meeting will be held as a virtual meeting and is open to the
public. Individuals who plan to view the virtual meeting and need
special assistance or other reasonable accommodations to view the
meeting, should notify the Contact Person listed below in advance of
the meeting. The meeting will be videocast and can be accessed from the
NIH Videocasting and Podcasting website (https://videocast.nih.gov/).
Name of Committee: Novel and Exceptional Technology and Research
Advisory Committee.
Date: November 9, 2020.
Time: 10:00 a.m. to 5:15 p.m.
Agenda: The Novel and Exceptional Technology and Research
Advisory Committee (NExTRAC) will include a workshop to examine
existing biosafety guidance for contained gene drive research and to
discuss potential conditions under which NIH could consider
supporting field release of gene drive-modified organisms.
Place: National Institutes of Health, 6705 Rockledge Drive,
Suite 750, Bethesda, MD 20892, (Virtual Meeting--Link for the
meeting will be available at https://osp.od.nih.gov/biotechnology/main-nextrac/#meetings).
Name of Committee: Novel and Exceptional Technology and Research
Advisory Committee.
Date: November 10, 2020.
Time: 10:00 a.m. to 5:15 p.m.
Agenda: The Novel and Exceptional Technology and Research
Advisory Committee (NExTRAC) will include (1) a workshop to examine
existing biosafety guidance for contained gene drive research and to
discuss potential conditions under which NIH could consider
supporting field release of gene drive-modified organisms, and (2)
discussion of a draft report conceptualizing a framework for NExTRAC
deliberation of issues surrounding emerging biotechnologies.
Place: National Institutes of Health, 6705 Rockledge Drive,
Suite 750, Bethesda, MD 20892, (Virtual Meeting--Link for the
meeting will be available at https://osp.od.nih.gov/biotechnology/main-nextrac/#meetings).
Contact Person: Kinshasa Letts, Office of Science Policy,
National Institutes of Health, 6705 Rockledge Drive, Suite 750,
Bethesda, MD 20892, 301-496-9838, [email protected].
To sign up to make an oral public comment, please submit your
name, affiliation, and short description of the oral comment to the
Contact Person listed above by 5:00 p.m. EST, November 3, 2020. Sign
up will be restricted to one sign up per email and oral comments
will be limited to two minutes. Once all time slots are filled, only
written comments will be accepted. Any interested person may file
written comments by forwarding their statement to the Contact Person
listed on this notice. The Contact Person should receive any written
statements by 5:00 p.m. EST, November 5, 2020.
Information is also available on the NExTRAC web page: https://osp.od.nih.gov/biotechnology/main-nextrac/#meetings, where an agenda
and any additional information for the meeting will be posted when
available. The Draft Report of the Working Group to Establish a
NExTRAC Framework will be posted prior to the meeting. Please check
this website for updates.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: October 7, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-22600 Filed 10-9-20; 8:45 am]
BILLING CODE 4140-01-P
